XERS Xeris Biopharma Holdings Inc

$XERS And who remembers $1.2 after the Strongbridge acquisition in 2021 When AC and Brodman were all over us.....Bashing! We hung in there for 5 years! For all of those who blocked me, sorry! IDC. Never forget your Princess, We did prevail, and I knew we would. Lot's more to come. In Celebration of the best investment ever ........🧜‍♀️ Let's Freaking go! XERS!🧜‍♀️🧜‍♀️🧜‍♀️

$XERS I bought this stock in early 2024, and I'm so gad I did. Truly found a gem. This is the largest position in my portfolio. If a buyout takes place anywhere between $25-$40, it will be life-changing for myself and my family. Thanks be to God!

$XERS Wow. This is 10x the price a few years ago when Brodman was bashing and some of us were loading up at 1.05. GL longs! You all deserve it! Special thanks to some of the OGs who did so much research and helped me to understand the potential here.

$XERS - many of us have been here a long time - endured those convertibles, the shorts, and the FUD boys - 5 years ago, we would have sold at $6. We have come a long way and are holding strong! We deserve this and are not selling out!

$XERS Wow, a dollar a day. I think a few years ago I dreamed about this and even posted about it. Nice.

$XERS A big bidding war would be nice. $40.00 or more. if any less don't sell. I am good to wait. I have been waiting for 7 years. I can wait a little longer.

$XERS They have to say "we're not for sale", and it means absolutely nothing... They need to float a price before anything becomes real. That's when we will know whether it's a real offer...

$XERS My thoughts re the price increase the last few trading days is that the stock is being accumulated in anticipation of a buyout in the $24 price range.. I see a rapid jump in share price in the coming days. This is time to accumulate a substantial position. There are so many positive catalysts that can propel the stock price into the $20’s.. An easy double here no matter if takeover takes place or not! Bought huge position today..

$XERS “If Xeris continues to reject Lundbeck’s acquisition offers, Lundbeck will probably try to accumulate as many shares as possible on the open market by year-end.

$XERS $20.27 *I’m not posting because there’s nothing to post. Steady growth. Big catalyst incoming. It’s not sexy but I don’t need sexy, I need sustainable returns that beat market baskets.

$XERS no doubt someone large is pushing this up, every EOD last 10 minutes large orders of 50k or 100k pushing bid/ask up into the close, regardless whether it's green or red at that time

$XERS Analyst Sentiment ShiftMultiple firms have raised targets recently:Leerink Partners: $12 → $16 (Outperform) Barclays: $9 → $12 (Overweight) Oppenheimer: Reiterated $18 (Outperform) Consensus rating is now Strong Buy, with an average target of $12.29 and a high target of $18 .

$XERS she is looking good early, but its not how you start the race its how you finish!!!!! LFG, XERS 2 THE MOON!!!!!

$XERS Whether Lundbeck is the real company behind the BO story or not, it puts $ XERS out there as a potential target. Our three current drugs are nice, and many other companies would love them, but XP-8121 is the real prize. In 5 years' time, there could be TWO $BILLION drugs for the taking... The big question is, where does the bidding start??? If we're at $1.82B now, is $3B a good starting point??? How about $5B ??? This one is NOT about current revenue; it's about Two Potential $BILLION Drugs, Recorlev & XP-8121... How much do you think Companies will pay for them???

$XERS We ain't seen nothing yet... Last year's peak -> $10 - November 2025 Based on the following fundamentals: A)$285–290M revenue (finished at $293M) B)Recorlev reached $139M by year-end C)A very successful Phase 2 trial for XP-8121. This year's main fundamentals -> A)$385–390M revenue B)QoQ-growing profits at this stage C)Recorlev approaching $250M (massive growth) D)XP-8121 should begin Phase 3 (multibillion-dollar blockbuster potential) Xeris in 2026 is double (possibly more) the asset it was in 2025. Keep it in mind.

$XERS Actually picked up 500 more shares today. adding to my Collection. Will be continuing to add regularly.. Extremely bullish..

$XERS Comparison: Xeris & Corcept Two main prospects with quite similar revenue potential Recorlev - blockbuster potential Korlym - blockbuster potential XP-8121 - up to $3B in the U.S. alone Relacorilant - up to $3B in potential sales Corcept has slightly better margins, although both companies boast top-tier margins. Xeris in the other hand has two additional franchises(Gvoke & Keveyis), plus its XeriJect and XeriSol tech ecosystem and commercial collaborations. Market Cap Valuation In 2025, before Relacorilant's approval, Corcept reached a $12B market cap peak, supported by $650–750M in Korlym revenue. Investors feared Relacorilant might not be approved, but the stock surged following its ovarian cancer approval. Corcept now commands a $13-14B market cap. By 2030, Xeris could very plausibly generate approximately $700-800M in revenue, with comparable revenue prospects and similarly exceptional margins. A 12B market cap would translate to approximately $70 per share.

$XERS I am going to make a guess that Amgen would enter the bidding war vs Landbeck. Their offer would most likely be an all cash offer and may be north of $20.00! This is going to be a wild day. waiting for algos and short covering to push this to $12 today .

$XERS yesterday was a significant day. For now I keep it at that. Been through too much ‘if’s & but’s’ + guessing over the past years. Let’s see what happens. (It beats going below $1 without reason though, I can tell you that. The OG’s will understand.)

$XERS I’ve been noticing this go up. I think it could hit $60. The all time chart is forming a huge cup and handle and if it breaks the all time high it could possibly hit $60